Guangzhou Insighter^® Biotechnology Co., Ltd. is a globally leading research-driven feed additive company founded by Dr. Xianfeng Peng in 2008. The company focuses on the research and development of high-value patented compounds for feed additives and new veterinary drugs. It has established chemical and integrated biology laboratories in the Guangzhou Science City International Enterprise Incubator and the South China New Drug Creation Center.

Insighter brings together nearly 40 multidisciplinary R&D professionals, with expertise spanning veterinary pharmacology, preventive veterinary medicine, medicinal chemistry, chemical process engineering, animal nutrition, pharmaceutical analysis, toxicology, and genetic engineering.

 
As of October 2025, Insighter has filed a total of 168 invention patent applications, including 73 in China, 33 PCT international applications, and 60 overseas invention patent applications. Currently, Insighter has been granted 99 invention patents.

Insighter has established chemistry and integrated biology laboratories at the Guangzhou Science City International Business Incubator and the South China New Drug Creation Center. It also operates a nearly  49.4 acres animal testing facility in Nanxiong, Guangdong, housing multiple animal species including pigs, chickens, rabbits, and companion animals. Additionally, Insighter owns a raw material plant and a feed additive formulation plant totaling 6.6 acres within the Nanxiong Fine Chemical Industrial Park—both of which have been certified under the ISO 9001 Quality Management System and the ISO 22000 Food Safety Management System.

Insighter^® was recognized as a national high-tech enterprise in 2014 and approved by the Guangdong Provincial Department of Science and Technology to establish the Guangdong Provincial New Feed Additive Discovery Engineering Technology Research Center in 2017. It was named a Guangzhou Agricultural Leading Enterprise and a Guangdong Province Specialized and Innovative Small and Medium Enterprise in 2021. In December 2020, Insighter^® licensed its anticoccidial compound invention patent to the leading multinational animal health company in the United States for three years for $1.5 million, marking the first time a Chinese livestock and veterinary industry company achieved a patent technology license-out.